InvestorsHub Logo
Followers 84
Posts 32220
Boards Moderated 85
Alias Born 03/22/2005

Re: None

Tuesday, 05/07/2019 12:12:22 PM

Tuesday, May 07, 2019 12:12:22 PM

Post# of 211
SNES - >>> California Bill AB1788 to Ban SGAR Rodenticides Clears Assembly

PR Newswire

May 6, 2019


https://finance.yahoo.com/news/california-bill-ab1788-ban-sgar-231800766.html


FLAGSTAFF, Ariz., May 6, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announces that California's AB1788, which will ban the use of Second Generation Anticoagulant Rodenticides (SGARs), has been passed by the State Assembly.

SenesTech, Inc. has developed an innovative technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company's first fertility control product, ContraPest(R), is marketed for use initially in controlling rat infestations.

"With this, California has moved a step closer to the creation of the California Ecosystems Protection Act of 2019 which will prohibit the use of the four major Second Generation Anticoagulant Rodenticides (SGARs) commonly used in rodent pest control. As the State of California moves toward a new paradigm in pest management it is becoming clear that the concept of balance between humans and animals is being demanded with a loud voice. We applaud the bold step in asking industry to come forward with a solution. We are working with industry professionals and end-users to add ContraPest, our fertility control flagship product, to their rodent management solution strategies," said Dr. Loretta Mayer, CEO of SenesTech. "There is a way to serve all with a new approach as US scientists have an answer."

The next steps for this bill is to go to the California Senate for approval and ultimately to Governor Newsom for signature. As this process moves forward SenesTech continues to prepare to serve the wildlife, citizens and environment of California.

About SenesTech

SenesTech is changing the paradigm of pest management by targeting the root cause of the problem: reproduction.

ContraPest® is an innovative technology with an approach that targets the reproductive capabilities of both sexes in rat populations, inducing egg loss in female rats and impairing sperm development in males. Using a proprietary bait delivery method, ContraPest® is dispensed in a highly palatable liquid formulation that promotes sustained consumption by rat communities. ContraPest® is designed, formulated and dispensed to be low hazard for handlers and non-target species such as wildlife, livestock and pets, where the active ingredients break down rapidly.

We believe ContraPest® will establish a new paradigm in rodent control, resulting in a decreased reliance on lethal options. For more information visit the SenesTech website at www.senestech.com.

<<<

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.